Boston Scientific (BSX) Accumulated Expenses (2009 - 2026)

Boston Scientific has disclosed Accumulated Expenses across 18 years of filings, most recently posting $2.8 billion for Q2 2026.

• In Q2 2026, Accumulated Expenses fell 1.47% year-over-year to $2.8 billion; the TTM figure through Jun 2026 stood at $2.8 billion (down 1.47% YoY), while the FY2025 annual figure was $3.2 billion, up 15.43% from the prior year.
• Accumulated Expenses came in at $2.8 billion for Q2 2026 at Boston Scientific, up from $2.5 billion in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $3.2 billion in Q4 2025 to a low of $1.9 billion in Q1 2023.
• Average Accumulated Expenses over 5 years is $2.4 billion, with a median of $2.3 billion recorded in 2024.
• Year-over-year, Accumulated Expenses fell 18.36% in 2022 and advanced 22.5% in 2023.
• Over 5 years, Accumulated Expenses stood at $2.2 billion in 2022, then climbed by 22.5% to $2.6 billion in 2023, then climbed by 4.8% to $2.8 billion in 2024, then climbed by 15.43% to $3.2 billion in 2025, then decreased by 13.9% to $2.8 billion in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $2.8 billion in Q2 2026, $2.5 billion in Q1 2026, and $3.2 billion in Q4 2025.